This compound is a fluorenylmethoxycarbonyl (FMOC)-protected amino acid building block featuring a 2,6-difluorophenyl substituent. It is employed in solid-phase peptide synthesis as a protected derivative of α-methyl-2,6-difluoro-DL-phenylalanine.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-fluorophenyl)-2-methylpropanoic acid
research compound
FMoc-alpha-Me-D-Phe(2-F)-OH
pharmaceutical intermediate
5-Fluoro-7-methyl-1H-indazole-3-carboxaldehyde
pharmaceutical intermediate
(1-Methyl-1H-1,2,4-triazol-3-yl)methanol
pharmaceutical intermediate
Fmoc-L-cysteine
pharmaceutical intermediate
3-Bromo-6-chloroimidazo[1,2-b]pyridazine
pharmaceutical intermediate
(S)-N-ALPHA-(9-FLUORENYLMETHYLOXYCARBONYL)-C-ALPHA-METHYL-2,6-DIFLUOROPHENYLALANINE
research compound
3-(2,6-difluorophenyl)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-2-methylpropanoic acid
MRIVYBRWULFPFJ-UHFFFAOYSA-N
CC(CC1=C(C=CC=C1F)F)(C(=O)O)NC(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24
—
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.